Using Patent Data to Assess the Value of Pharmaceutical Innovation |
| |
| Authors: | Aaron S. Kesselheim Jerry Avorn |
| |
| Affiliation: | Instructor in Medicine at Harvard Medical School and an Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital.;Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. |
| |
| Abstract: | Though many more patents emerge from industry sources, drug-related patents generated in the non-profit setting appear to have greater importance than patents arising from the commercial sector, which helps demonstrate the value non-profit research institutions can have in driving drug development. |
| |
| Keywords: | |
|
